Status:
UNKNOWN
Incidence, and Survival Medical Expenditure of Patients With Multiple Sclerosis
Lead Sponsor:
Chun-Ming Liao
Conditions:
Neurologic Signs and Symptoms
Eligibility:
All Genders
Brief Summary
Multiple sclerosis (MS) is a disease of autoimmune system which attacks the central nervous system and that is one of the most common inflammatory diseases and has caused a heavy disease burden on pat...
Detailed Description
The study population is based on the 'National Health Insurance Research Database' (NHIRD) from 2001 to 2015 provided by Taiwan Ministry of Health and Welfare. The subjects are diagnosed as MS patient...
Eligibility Criteria
Inclusion
- The subjects are diagnosed as MS patients
Exclusion
- The subjects are not diagnosed as MS patients
Key Trial Info
Start Date :
July 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 20 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04022564
Start Date
July 15 2019
End Date
May 20 2020
Last Update
July 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genetic and Rare Disease Center
Taichung, Taiwan, 404